# Intercepting Cancer When DNA Surveillance Fails

Page: https://stenobird.com/podcast/the-bio-report-1092382/intercepting-cancer-when-dna-surveillance-fails
Text version: https://stenobird.com/podcast/the-bio-report-1092382/intercepting-cancer-when-dna-surveillance-fails.md
Podcast: [The Bio Report](https://stenobird.com/podcast/the-bio-report-1092382)
Published: 2026-04-08T07:00:00+00:00
Episode link: https://thebioreport.podbean.com/e/intercepting-cancer-when-dna-surveillance-fails/
Audio file: https://mcdn.podbean.com/mf/web/8smnnp4ea8xvuktk/BR-Marina_Udier-4-9-26a25z1.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/intercepting-cancer-when-dna-surveillance-fails
Duration seconds: 2369

## Resource

Many people with the genetic condition Lynch syndrome live with the near‑certainty that they will one day develop cancer and have few options beyond constant screening and, in some cases, preventive surgery. Nouscom is trying to change that by training the immune system to spot and destroy cancer cells before tumors ever form. We spoke to Marina Udier, CEO of Nouscom, about the company’s experimental cancer vaccines, how they work, and the broader potential for the company’s off‑the‑shelf cancer therapies.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/intercepting-cancer-when-dna-surveillance-fails/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-bio-report-1092382/intercepting-cancer-when-dna-surveillance-fails.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.